NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 2D 1H-15N HSQC | 2 mM [U-100% 13C; U-100% 15N] HIV-1 CA C-terminal domain, 25 mM sodium phosphate, 2 mM DTT, 0.02 % sodium azide | 93% H2O/7% D2O | 25 | 6.5 | ambient | 298 | |
2 | 2D 1H-13C HSQC | 2 mM [U-100% 13C; U-100% 15N] HIV-1 CA C-terminal domain, 25 mM sodium phosphate, 2 mM DTT, 0.02 % sodium azide | 93% H2O/7% D2O | 25 | 6.5 | ambient | 298 | |
3 | 3D HNCACB | 2 mM [U-100% 13C; U-100% 15N] HIV-1 CA C-terminal domain, 25 mM sodium phosphate, 2 mM DTT, 0.02 % sodium azide | 93% H2O/7% D2O | 25 | 6.5 | ambient | 298 | |
4 | 3D HN(COCA)CB | 2 mM [U-100% 13C; U-100% 15N] HIV-1 CA C-terminal domain, 25 mM sodium phosphate, 2 mM DTT, 0.02 % sodium azide | 93% H2O/7% D2O | 25 | 6.5 | ambient | 298 | |
5 | 3D HNCA | 2 mM [U-100% 13C; U-100% 15N] HIV-1 CA C-terminal domain, 25 mM sodium phosphate, 2 mM DTT, 0.02 % sodium azide | 93% H2O/7% D2O | 25 | 6.5 | ambient | 298 | |
6 | 3D HN(CO)CA | 2 mM [U-100% 13C; U-100% 15N] HIV-1 CA C-terminal domain, 25 mM sodium phosphate, 2 mM DTT, 0.02 % sodium azide | 93% H2O/7% D2O | 25 | 6.5 | ambient | 298 | |
7 | 3D HBHA(CO)NH | 2 mM [U-100% 13C; U-100% 15N] HIV-1 CA C-terminal domain, 25 mM sodium phosphate, 2 mM DTT, 0.02 % sodium azide | 93% H2O/7% D2O | 25 | 6.5 | ambient | 298 | |
8 | 3D HCCH-TOCSY | 2 mM [U-100% 13C; U-100% 15N] HIV-1 CA C-terminal domain, 25 mM sodium phosphate, 2 mM DTT, 0.02 % sodium azide | 93% H2O/7% D2O | 25 | 6.5 | ambient | 298 | |
9 | 3D simultaneous 13C,15N-edited NOESY | 2 mM [U-100% 13C; U-100% 15N] HIV-1 CA C-terminal domain, 25 mM sodium phosphate, 2 mM DTT, 0.02 % sodium azide | 93% H2O/7% D2O | 25 | 6.5 | ambient | 298 | |
10 | 3D 13C/15N-filtered, 13C-edited NOESY | 1.4 mM [U-100% 13C; U-100% 15N] HIV-1 CA C-terminal domain, 1.4 mM NATURAL ABUNDANCE HIV-1 CA C-terminal domain, 25 mM sodium phosphate, 2 mM DTT, 0.02 % sodium azide | 93% H2O/7% D2O | 25 | 6.5 | ambient | 298 | |